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A multidisciplinary approach to hemodialysis access: Prospective eval-
uation. Dialysis access procedures and complications represent a major
cause of morbidity, hospitalization and cost for chronic dialysis patients.
To improve outcomes and reduce the cost of hemodialysis access proce-
dures we developed a multidisciplinary approach, involving nephrologists,
access surgeons, and radiologists. A full-time dialysis access coordinator
scheduled all access procedures with the surgeons and radiologists, and
tracked outcomes. A computerized database was developed for prospec-
tive documentation of procedures and complications. Confidential, de-
tailed analyses and recommendations for improvements were provided
periodically to the surgeons and radiologists. The major changes arising
from the multidisciplinary approach were as follows: (1) The approach to
clotted grafts evolved from an inpatient surgical procedure to an outpa-
tient radiologic procedure. The immediate technical success rate of graft
declots increased from 48% to 69%. (2) Elective placement of arterio-
venous (A-V) grafts evolved from a three-day inpatient hospitalization to
a largely outpatient procedure. The proportion of A-V grafts placed as
same day surgery or outpatient surgery increased from 16% to 81%. (3)
Surgical complications of new A-V graft surgery decreased from 25% to
11%. (4) Aggressive detection and correction of graft stenosis decreased
the incidence of graft thrombosis by 60%, from 0.70 to 0.28 events per
patient-year. (5) The proportion of native A-V fistula construction in new
dialysis patients increased from 33% to 69%. In conclusion, an integrated
multidisciplinary approach markedly reduced surgical complications of
access surgery and decreased access failures. These improvements oc-
curred despite a marked decrease in hospitalization for access procedures,
with a substantial cost saving.
Dialysis access procedures and complications of dialysis access
represent a major cause of morbidity, hospitalization and cost for
chronic dialysis patients [1–4]. Over 20% of hospitalizations in
hemodialysis patients in the United States are access-related, and
the annual cost of access morbidity is close to $1 billion [4]. The
three types of hemodialysis access, in order of preference, are
native arteriovenous (A-V) fistulas, polytetrafluoroethylene
(PTFE) A-V grafts, and temporary catheters placed in a central
vein. Due to inadequate vessels many hemodialysis patients
require A-V grafts, and a minority require temporary dialysis
catheters.
Until the middle of 1995 the approach to construction, main-
tenance, and repair of hemodialysis access at our medical center
was considered highly unsatisfactory by our nephrologists, access
surgeons, and patients. We had approximately 350 chronic hemo-
dialysis patients under the care of eight clinical nephrologists. The
A-V grafts clotted at a high frequency. When they clotted, each
nephrologist’s secretary would contact the Surgery office and
schedule a declot procedure. The typical wait for this elective
procedure was three to five days. In the meantime, the patient
would dialyze temporarily with a femoral catheter. Most of our
nephrologists and surgeons felt that, due to the medical complex-
ity of these patients, it was inadvisable to have access procedures
performed in the oupatient setting. In most cases the patient was
admitted to the Renal Ward Service on the day before the
scheduled access procedure, and was observed overnight follow-
ing the procedure. An elective graft declot typically required a
three-day hospitalization. In about 50% of cases the declot was
unsuccessful, and the patient had to be scheduled for construction
of a new A-V graft three to five days later. This required more
outpatient hemodialysis treatments using a femoral catheter,
another three-day hospitalization, significant discomfort for the
patients, extra workload for our inpatient dialysis units, and
chronic dissatisfaction by the nephrologists. There was little
systematic effort to screen for graft dysfunction, so as to intervene
in an effort to minimize graft thrombosis. Even placement of
temporary central dialysis catheters (simple or tunneled) was
difficult to schedule because of the hectic surgery schedules;
moreover, these catheters frequently malfunctioned.
This manuscript describes how over the past two years we have
been able to develop an efficient, multidisciplinary approach to
hemodialysis access. The highlights of this approach have in-
cluded: (1) establishing a Dialysis Access Service with a full-time
access coordinator to schedule and track all dialysis access pro-
cedures; (2) prospective, computerized records to track outcomes;
(3) involvement of interventional radiologists, sonologists, and
access surgeons in delivering access services; (4) periodic, detailed
and specific feedback to decrease complication rates; (5) gradual
transition from a largely inpatient service to a primarily outpatient
service; (6) aggressive screening for graft stenosis and appropriate
intervention to prevent thrombosis; (7) a concerted effort to
Key words: hemodialysis, vascular access, thrombosis, stenosis, dialysis
access procedures.
Received for publication July 10, 1997
and in revised form September 15, 1997
Accepted for publication September 15, 1997
© 1998 by the International Society of Nephrology
Kidney International, Vol. 53 (1998), pp. 473–479
473
increase the construction of A-V fistulas in preference to A-V
grafts; and (8) continuous quality improvement.
METHODS
Patient population
The University of Alabama at Birmingham provides chronic
dialysis to approximately 450 patients, including about 350 in-
center hemodialysis patients and about 100 home dialysis patients.
The total number of dialysis patients followed by our medical
center has remained relatively stable during the study period.
There are four outpatient dialysis units, including a hospital-based
dialysis unit, and three satellite units. The demographics of our
patient population are as follows: 28% of the patients are age 65
or older; 49% of the patients are female; 82% of the patients are
black and 18% are white; and 37% of the patients have diabetes.
As of February 1997 about 26% of the hemodialysis patients were
dialyzing with A-V fistulas, 61% had polytetrafluoroethylene
(PTFE) A-V grafts, and 13% had temporary dialysis catheters.
The medical care of these patients is provided by eight clinical
nephrologists, all of whom are full-time University faculty in the
Division of Nephrology. All patient hospitalizations, surgical
procedures, and radiologic procedures are done at UAB Hospital.
Dialysis access procedures are performed by the transplant sur-
geons, and radiologic diagnostic tests and interventions for dial-
ysis access are performed by members of the Department of
Radiology.
Graft thrombosis
Given the reluctance to perform surgical graft declots on an
outpatient basis, and the long delays in scheduling such proce-
dures, we approached the interventional radiologists in June 1995
about the possibility of outpatient thrombolysis. The radiologists
embraced this approach enthusiastically, and were prepared to
provide the service with two working days in the majority of cases.
In addition to the outpatient nature of these procedures, several
other advantages were apparent: (1) The declot was immediately
followed by venography with angioplasty of stenosis, when found.
(2) When the declot was unsuccessful, a temporary internal
jugular dialysis catheter was placed under ultrasound guidance
during the same procedure. (3) Detailed definition of the relevant
vascular anatomy permitted the surgeon to plan the optimal
access procedure when the declot procedure was unsuccessful.
During the first year the technique used was pharmacomechanical
thrombolysis, involving a combination of clot dissolution with
urokinase and mechanical disruption of the thrombus [5–9]. In
September 1996 an alternative method of declot was introduced,
using the Amplatz thrombectomy device [10]. The device consists
of a small propeller enclosed in a metal housing. After it is
introduced into the thrombus, the propeller rotates at about
150,000 rpm and macerates the clot into tiny particles that enter
the bloodstream. The Amplatz approach was associated with a
higher technical success rate, and avoided the risk of anticoagu-
lation.
Access service
We hired a physician assistant (R.B.) as a full-time dialysis
access coordinator. He had many years of experience in dialysis
and was very familiar with dialysis access issues. He was placed in
charge of scheduling all dialysis access procedures with both
surgery and interventional radiology. He was the main liaison
betwen the nephrologists, surgeons, and radiologists, thereby
providing consistency of communication. He provided the sur-
geons and radiologists with the relevant patient medical records,
and provided the nephrologists with prompt feedback about the
outcome of scheduled procedures. If a graft declot by interven-
tional radiology was unsuccessful, he would immediately schedule
graft revision or construction of a new dialysis graft by the
surgeons. Periodic meetings were held among the access coordi-
nator and representatives of the nephrologists (M.A.), access
surgeons (M.H.D.), and radiologists (S.S.) to discuss problems
and potential solutions.
Retrospective review of surgical access procedures
Our experience was analyzed retrospectively for the six month
period between 8/1/95 and 1/31/96. This period of time was chosen
for two reasons. First, R.B. started as our dialysis access coordi-
nator on 8/1/95. Since that time, he had been responsible for
scheduling and coordinating all access procedures both with the
Department of Surgery and with the Department of Radiology
Interventional Radiology, providing a high level of confidence in
the accuracy of the information. Second, we started utilizing the
services of interventional radiology in June 1995, so these data
reflected our current pattern of utilizing both access surgery and
interventional radiology, in order to deliver the most efficient
dialysis access service to our patients. For purposes of compari-
son, we performed a limited analysis of the six-month period
between 1/1/95 and 6/30/95. The data for each dialysis access
procedure was entered into a computerized data file (Filemaker
Pro 2.0). The following information was included: patient name
and medical record number, surgeon, date of procedure, type of
procedure. The information collected was provided confidentially
to the access surgeons, with specific recommendations for
changes.
Prospective review of surgical access procedures
In April 1996 we began to maintain a computerized data file to
track these procedures prospectively. The experience from the
first four months (4/1/96 to 7/31/96) was analyzed in detail, and a
confidential report provided to the access surgeons, along with
specific recommendations. Subsequently, our experience with
dialysis access surgery was collected prospectively for an addi-
tional six-month period and the data analyzed again. Complica-
tions of new dialysis A-V graft procedures were determined in the
following manner. All the data were entered in a Filemaker Pro
2.0 software program for analysis. It was sorted by patient and
date. The list was then scanned systematically. Surgical complica-
tions were defined prospectively as any procedure associated with
primary graft failure (the graft was not functioning at the time the
patient returned from the operating room to the hospital bed) or
requiring a second surgical procedure (declot, revision, removal,




During the period of the retrospective review and prospective
tracking the dialysis patients at our facilities required hundreds of
dialysis access procedures (Tables 1 and 2). The volume of
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surgical access procedures decreased by 15% between the retro-
spective period and the first prospective period, and by an
additional 20% between the first and second prospective periods.
In contrast, the volume of access procedures performed by
interventional radiology remained relatively constant between the
first and second prospective tracking periods.
Graft thrombosis
In the six months preceding referral of clotted A-V grafts to
interventional radiology (January to June 1995) a total of 75 grafts
were declotted by the access surgeons. Retrospective review
revealed that in 39 of the cases the declot procedure was
technically unsuccessful. Thus, only 48% of grafts were patent by
the next scheduled hemodialysis treatment. In addition, a propor-
tion of the grafts that was initially patent following the declot
procedure rethrombosed within a few days of the patient’s
discharge from the hospital. (Due to the retrospective nature of
this analysis, this proportion could not be quantified). Patients
whose graft declot was unsuccessful underwent either a repeat
declot with a surgical revision or construction of a new A-V graft.
Because the repeat surgical procedure could rarely be scheduled
promptly, the patients dialyzed as an outpatient using a femoral
catheter, and were then readmitted for the second dialysis access
procedure.
Utilization of interventional radiology for clotted grafts re-
sulted in an immediate and dramatic decrease in the workload
devoted to access procedures on the inpatient service. The declot
procedure was always performed in conjunction with a fistulogram
to define the graft anatomy, as well as angioplasty of stenosis in
the graft or the proximal veins, when indicated. When declots
were unsuccessful, a temporary dialysis catheter was placed in the
internal jugular vein for temporary dialysis access. The anatomic
information was provided to the access surgeon, who decided
whether to attempt a surgical graft revision or construct a new
dialysis graft. As a result of the detailed anatomic information,
when a surgical declot was performed after a failed declot by
interventional radiology, it was more commonly performed in
conjunction with a graft revision (Table 3). Nevertheless, in the
first prospective period (4/1/96 to 7/31/96) it became apparent that
the majority of surgical declots attempted following an unsuccess-
ful declot by radiology were unsuccessful (Table 3). Of seven such
procedures attempted, only one was technically successful. Once
we provided the access surgeons with these data, they abandoned
this approach, and began to routinely place new dialysis grafts
when declot attempts by interventional radiology were unsuccess-
ful.
Pharmacomechanical thrombolysis was well-tolerated by the
patients, with the exception of one case of prolonged bleeding.
However, the immediate technical success of the declots by
interventional radiology during the initial prospective period was
disappointing, as it was no better than that obtained previously
with surgical declots (45% vs. 48%). The impression of the
interventional radiologists was that pharmacomechanical graft
thrombolysis was inadequate in terms of clearing all the thrombus.
Therefore, in September 1996 they began using an alternative
technique involving the Amplatz thrombectomy device [10].
This approach was associated with a much better technical
outcome, such that the immediate technical success rose by
over 50%, from 45% to 69%. Changes in patient Kt/V after
successful graft declot and angioplasty were analyzed retro-
spectively for 20 cases in which a Kt/V was available within one
month before and after the procedure. The Kt/V increased
significantly in those patients, from 1.30 6 0.07 to 1.44 6 0.06
(P , 0.001).
Location of dialysis access procedures
Retrospective review of the surgical access procedures per-
formed in the six-month period between 8/1/95 and 1/31/96
revealed that the vast majority were performed on an inpatient
basis (Table 4), typically with the patient admitted to the hospital
on the day before surgery, and discharged on the day following
surgery (3-day hospitalization). Most of the cases performed as
same day surgery were scheduled as such when the patient’s
insurance company would not certify the procedure to be per-
formed on an inpatient basis. A concerted effort was made to
shorten hospital stays for elective dialysis access procedures. Over
a 15-month period we were able to shift a large majority of these









New A-V graft 79 60 63
























Procedures/month 41 35 28
a Other surgical access procedures include: removal of tunneled dialysis
catheter, graft ligation, and graft banding.






















Place simple catheter 67 41 43
Other N/A 3 10
Total N/A 181 262
Procedures/month N/A 45 44
N/A is not available.
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procedures from inpatient procedures requiring a three-day hos-
pitalization to outpatient procedures. This transition was regarded
with apprehension at the outset by many of the nephrologists and
access surgeons, who expressed concerns about the safety of such
an approach. Thus, we incrementally moved from inpatient access
surgery to same day surgery with overnight hospitalization to same
day surgery with discharge on the evening of the surgery to
outpatient surgery (Table 4). Each transition was implemented
initially with patients felt to be the most medically stable, and
subsequently generalized to sicker dialysis patients. With careful
prospective monitoring we were able to convince all the physicians
that performing elective access surgery as an outpatient procedure
was safe.
Complications of surgical access procedures
We prospectively evaluated the surgical complications of dial-
ysis access procedures, focusing primarily on the outcomes of new
A-V grafts. In the first prospective period (April to July 1996) 15
of 60, or 25% of all new graft procedures resulted in a surgical
complication: 6 primary failures; 1 severe steal syndrome requir-
ing surgical intervention; 5 graft thromboses within a month of
surgery; and 3 graft infections requiring graft removal. The
ramifications of these 15 surgical complications were staggering.
By a conservative estimate, the complications related to these 15
A-V grafts resulted in 57 additional dialysis access procedures.
These included 16 additional surgical access procedures (declot,
removal of infected graft, ligation of graft, or construction of new
graft); 13 additional procedures by interventional radiology
(placement of simple or tunneled temporary dialysis catheter),
and 28 additional procedures by nephrology (placement of fem-
oral dialysis catheters). Thus, each complication of an elective
A-V graft placement resulted in the need for an average of four
additional dialysis access procedures. Other ramifications that
were more difficult to quantify included: (1) additional hospital
days, (2) increased workload on the inpatient dialysis nurses, (3)
infections related to temporary dialysis catheters, (4) increased
waiting period for elective surgical access procedures, (5) loss of
potential access sites for hemodialysis patients, and (6) significant
discomfort to our dialysis patients.
A detailed list of the surgical access procedures and their
complications was provided confidentially to the surgeons. Dis-
cussion of these data among the nephrologists and access sur-
geons led to more careful selection of vessels to be used for
construction of A-V grafts, and more liberal use of studies to
define the vascular anatomy ahead of time (venogram or Doppler
ultrasound). Following these recommendations we evaluated the
outcomes of elective A-V grafts prospectively for an additional six
months (8/1/96 to 1/31/97). Overall, 7 of 63, or 11% of all new
graft procedures resulted in a surgical complication: 5 primary
failures and 2 graft infections requiring graft removal. This
Table 3. Management of clotted grafts: Evolution over time









Surgical declots per month 12.5 3.3 1.7 0.2
Declot alone 8.7 (70%) 1.8 (54%) 0.2 (12%) 0 (0%)
Declot 1 revision 3.8 (30%) 1.5 (46%) 1.5 (84%) 0.2 (100%)
IR declots per montha 0 7.0 7.2 4.8
Total declot procedures per month 12.5 10.3 8.9 5.0
Immediate technical successb
Access surgeryc
48% N/A 14% 0%
Interventional radiology N/A 52% 45% 69%
Abbreviations are: IR, interventional radiology; NA, not applicable or not available
a IR declots performed using pharmacomechanical thrombolysis from 8/1/95 to 8/31/96, and by the Amplatz thrombectomy device starting on 9/1/96
b Immediate technical success—graft patent until the next hemodialysis treatment
c After 8/1/95 surgical declots were only performed if the declot attempt by IR was unsuccessful










Inpatienta 66 (84%) 36 (60%) 16 (25%) 8 (19%)
Same day surgery—Admitb 13 (16%) 24 (40%) 3 (5%) 5 (12%)
Same day surgery—Dischargec 0 0 44 (70%) 18 (43%)
Outpatientd 0 0 0 11 (26%)
Total number of new grafts 79 (100%) 60 (100%) 63 (100%) 42 (100%)
Total number of hospital days 224 156 98 52
Estimated hospital coste $108,192 $75,348 $47,334 $25,116
Estimated hospital cost per graft $1370 $1256 $751 $598
a Patient admitted to the hospital on the day before the scheduled procedure, and observed overnight following the surgery (3-day hospitalization)
b Patient admitted to the hospital after the surgical procedure for overnight observation (2-day hospitalization)
c Patient admitted to the hospital after the surgical procedure and discharged home that same everning (1-day hospitalization)
d Surgery performed in the outpatient clinic (no hospitalization)
e Estimated hospitalization cost @ $483/day (does not include charge for procedures, medications, physician bills, dialysis, etc.)
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dramatic improvement occurred in spite of shortened hospitaliza-
tions for these procedures (Table 4).
Surveillance for graft stenosis
Aggressive surveillance for persistent elevation of dialysis ve-
nous pressures (DVP) at a low blood flow during initiation of
dialysis, and referral of such patients for elective fistulogram and
angioplasty [1] only modestly decreased (by 29%) the frequency of
clotted grafts (Table 3). Retrospective review of the dialysis flow
sheets in patients whose graft clotted, and whose subsequent
fistulogram revealed significant graft stenosis, revealed that many
of these patients had never had elevations of their DVP. We
began utilizing additional clinical findings to refer patients for
fistulograms, including (a) prolonged bleeding from needle punc-
ture sites in the graft; (b) delivered Kt/V . 0.2 units lower than
the predicted Kt/V; and (c) abnormal graft auscultation. This
concerted approach resulted in a large volume of fistulograms
(Table 2), as well a 44% reduction in graft declot procedures
between the first prospective period (4/1/96 to 7/31/96) and the
second prospective period (8/1/96 to 1/31/97; Table 3). Overall,
aggressive screening for graft stenosis decreased the frequency of
graft declot procedures by 60% during the two-year period
monitored, from 0.70 to 0.28 events per patient-year.
Emphasis on arteriovenous fistulas
Although the literature clearly shows that A-V fistulas are
superior to grafts, only a minority of our new dialysis patients were
receiving fistulas. We undertook a concerted effort to increase
placement of native A-V fistulas, with an emphasis on upper arm
(brachiocephalic) fistulas when the forearm vessels were inade-
quate. Specifically, if the forearm vascular anatomy was unsuitable
for construction of a forearm A-V fistula, the surgeons con-
structed an upper arm fistula, rather than a forearm A-V graft.
There was a dramatic improvement in the proportion of new
dialysis patients receiving fistulas in the subsequent three-month
period (February to April 1997; Table 5). The change was
particularly striking in female patients.
DISCUSSION
We have demonstrated in a large, prospective study that an
integrated approach involving nephrologists, access surgeons, and
radiologists resulted in a marked reduction in complications of
surgical access procedures, a decrease in the frequency of graft
thrombosis, improved success of graft declot procedures, and an
increase in the proportion of A-V fistulas. These favorable
outcomes have been achieved concurrently with a shift of dialysis
access procedures from the inpatient service to the outpatient
arena, representing a huge cost savings. Each of the measures
introduced in the course of this study was based on recommen-
dations in the medical literature derived from retrospective or
prospective studies. What distinguishes the present report from
previous publications is the prospective tracking of outcomes in
hundreds of dialysis patients at a single medical center during the
implementation of several major changes in the approach to
dialysis access management.
Arteriovenous grafts are used in patients whose vascular anat-
omy does not permit construction of a native A-V fistula. The
longevity of PTFE dialysis grafts is shorter than that of A-V
fistulas [11–14], and they are more prone to recurrent stenosis,
thrombosis, and infection [15]. Optimizing the longevity of each
A-V graft is essential in order to assure adequate hemodialysis
access for patients. This requires selection of adequate vessels for
construction of the A-V graft, optimal surgical technique to
minimize surgical complications, constant vigilance for evidence
of graft stenosis, aggressive screening and correction of graft
stenosis by angioplasty or surgical graft revision, and optimal
declot of grafts that thrombose in spite of all these efforts. In the
present report we have documented the results of specific efforts
to optimize each of these aspects.
Detailed and specific feedback to the access surgeons regarding
complications of A-V graft surgery, accompanied by specific
suggestions, resulted in a dramatic decrease in the incidence of
surgical complications within one month following construction of
new A-V grafts. Using a similar definition of surgical complica-
tion, a number of investigators have reported a 5 to 15% incidence
of graft failure within one month of surgery [13, 16–20]. We were
able to decrease the surgical complications of new A-V grafts at
our institution from 25% to 11%, well within the frequency
reported in the literature. This improvement probably accounted,
in part, for the 30% decrease in frequency of new A-V grafts
between the first and second prospective tracking periods, from
15.0 to 10.5 procedures per month (Table 1).
The leading cause of dialysis graft thrombosis is stenosis of the
venous anastomosis or of a more proximal draining vein [1].
Aggressive surveillance for suspected graft stenosis, with referral
for fistulogram and angioplasty (or surgical revision) as indicated,
resulted in a dramatic (60%) decrease in grafts requiring declots
(Table 3), in agreement with previous publications [21–23]. Ele-
vated dynamic dialysis venous pressure, a measure reported to be
highly predictive of graft stenosis [21, 24, 25], was found to be
relatively insensitive. Elevated static dialysis venous pressure
appears to be a more sensitive index of graft stenosis, but its
measurement requires expensive equipment and is more opera-
tor-dependent [23]. It was only when we began to utilize multiple
criteria to screen for graft stenosis (failure to achieve prescribed
Kt/V, prolonged bleeding from graft needle puncture site, or
Table 5. Incidence of dialysis access type (fistula vs A-V graft) in new hemodialysis patients by patient sex
4/1/96 to 1/31/97 2/1/97 to 4/30/97
Fistula Graft
Percent pts




pts with fistula (1986–87)a
Male 10 7 59% 12 6 67% 53%
Female 5 23 18% 8 3 73% 33%
Total 15 30 33% 20 9 69% 44%
a Adapted from [27], used with permission
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abnormal graft auscultation) [26] that we were able to make a
significant dent in the frequency of graft thrombosis.
Attempts at surgical declots and revision following unsuccessful
attempts at declotting thrombosed grafts by interventional radi-
ology were almost uniformly futile. Thus, such patients required
construction of an A-V graft at a new site. Changing from the
pharmacomechanical method of declot to the Amplatz thrombec-
tomy device between the first and second prospective tracking
periods decreased the rate of unsuccessful declots by interven-
tional radiology from 55% to 31% (Table 3). Taken in conjunction
with the simultaneous decrease in grafts requiring declot, the
number of unsuccessful declots by interventional radiology de-
creased by 62%, from 4.0 (7.2 3 0.55) to 1.5 (4.8 3 0.31) per
month, between the two prospective tracking periods. This dra-
matic improvement is likely to translate into enhanced longevity
of A-V grafts in our dialysis population.
The most effective way to reduce repeated dialysis access
procedures is to place native A-V fistulas as often as possible [4].
There are striking regional differences in the proportion of
hemodialysis patients receiving fistulas [27], that persist after
adjustment for patient age, diabetes, and peripheral vascular
disease. The proportion of fistulas as percent of new hemodialysis
access in 1986 to 1987 was 35%, ranging from a low of 15% in the
East South Central region (which includes our medical center) to
77% in New England. A concerted effort to increase the percent
of fistula placements in new hemodialysis patients at our medical
center, with an emphasis on upper arm (brachiocephalic) fistulas,
had a dramatic effect, particularly in female patients (Table 5).
Similarly, Sands and Miranda [28] increased the frequency of
fistula construction in their hemodialysis patients from 28% to
44% by increasing the awareness about this issue. Clearly, a more
aggressive approach to creation of A-V fistulas may result in a
number of failures in patients with marginal vascular anatomy.
The results of this study have major economic implications,
especially in the era of Managed Care in the United States. The
cost of hospitalization contributes substantially to the overall cost
of dialysis access procedures. By shifting elective A-V graft
procedures primarily from inpatient procedures to procedures
performed as same day surgery or in the outpatient clinic, we were
able to substantially decrease the hospitalization cost associated
with this surgical procedure (Table 4). Of course, the cost for
physician services, anesthesia, and operating room fees was not
affected by this change. Similarly, declotting a graft by interven-
tional radiology rather than by access surgery eliminated the cost
of the operating room and the anesthesiologist.
Under fee-for-service reimbursement performance of more
access procedures results in greater financial renumeration. In
contrast, under a capitated reimbursement schedule the more
access procedures that are performed, the less money the hospital
and physicians receive. Thus, there is a strong incentive to
minimize dialysis access procedures and to perform them in the
outpatient arena. Inpatient dialysis access procedures would be
reserved for emergencies, such as infected grafts or ruptured
aneurysms. From this perspective, one should place as many
fistulas as possible, screen aggressively for graft stenosis, minimize
the need for temporary dialysis catheters, and use strict aseptic
techniques for dialysis access care. An integrated, multidisci-
plinary approach with prospective tracking of outcomes, such as
described in this article, is likely to reduce patient morbidity and
hospitalization, as well as decrease the cost of patient care. A
full-time dialysis access coordinator may not be feasible in smaller
dialysis programs; however, a similar role could be fulfilled by a
dialysis nurse.
Reprint requests to Michael Allon, M.D., Division of Nephrology, 1809
Fifth Avenue South, ADU 129, Birmingham, Alabama 35233, USA.
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